Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Summary information of lipid-lowering drug categories, targets, and encoding genes

From: Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

Drug categories

Drug targets

Encoding genes

Gene region(in GRCh37 from Ensembl)

HMGCR inhibitors

3-hydroxy-3-methylglutaryl coenzyme A reductase

HMGCR

Chromosome 5: 74,632,154-74,657,929

PCSK9 inhibitors

proprotein convertase subtilisin/kexin type 9

PCSK9

Chromosome 1: 55,505,221-55,530,525

NPC1L1 inhibitors

Niemann-Pick C1-Like 1

NPC1L1

Chromosome 7: 44,552,134-44,580,914

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us